NCT06708858 2024-11-27Phase â…¡ Clinical Study of Surufatinib Combined With Gemcitabine and Cisplatin Plus Durvalumab/Pembrolizumab Regimen in the Treatment of Advanced Biliary Tract CancerChinese PLA General HospitalPhase 2 Recruiting35 enrolled